Plexium, Inc. (Plexium), a leading next-generation targeted protein degradation company, today announced that initial Phase 1 clinical results with PLX-4545, a selective IKZF2 molecular glue degrader, ...

Led by a team of distinguished toxicology experts, TriApex was thrilled to take part in this prestigious meeting, engaging in ...

BSU students found recent success at the 11th annual Posters at the Capitol event in St. Paul, with two undergraduate ...

Once you reach a certain level of wealth, you may be inclined to treat yourself to different luxuries. That could mean taking ...

Katie Medrano, program manager in the Office of Research and Sponsored Programs, noted that three performers (a band, Cade ...

Posters have been put up in the capital demanding the removal of several government bureaucrats. These posters are on the ...

WKU will host the 55th Annual Student Scholar Showcase on Saturday, April 5, featuring 233 graduate and undergraduate ...

EpimAb Biotherapeutics, a clinical stage biotechnology company specializing in the development of bispecific antibodies and T ...

Session Date and Time: Monday, April 28, 2:00 - 5:00 p.m.

today announced upcoming poster presentations including one for CM24 in the treatment of pancreatic cancer, and two for NT219 in the treatment of colorectal and head and neck cancers, at the 2025 ...

The Electoral Commission in Ireland is looking to seek the public’s views on the use of election posters in future elections ...

Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced 11 oral and poster presentations ...